NOVIGENIX
Business Description Novigenix is a precision medicine firm based in Switzerland that develops ImmunoTranscriptomic technologies for illness identification, therapeutic optimization, and disease recurrence monitoring in order to enhance disease management and patient outcomes.
By combining patient multi-omics data, advanced Machine Learning, and artificial intelligence approaches, the Novigenix proprietary LITOseek platform is optimised for mapping the immune system's response to the onset and progression of disease, providing actionable insights and precision solutions for optimising the therapeutic journey of patients. Our current product roadmap includes immuno-oncology patient stratification tools, colorectal cancer early detection and recurrence monitoring, and therapy optimization systems for cancer patient management.
Tags Artificial Intelligence, Biotechnology, Health Diagnostics, Life Science, Machine Learning, Predictive Analytics
Website https://www.novigenix.com
Articles about NOVIGENIX:
💡 You're a corporate or investor and looking for startups that are innovating in the same market as
NOVIGENIX? We're happy to assist you with our
Startup Sourcing service.